Acadia Pharmaceuticals Inc

ACAD

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001070494

SEC filings (opens in a new tab)

In the last 90 days, Acadia Pharmaceuticals Inc insiders filed 0 open-market purchases and 2 sales; 354 institutions reported holding it in 13F filings for Q2 2026, worth $4.27B in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Acadia Pharmaceuticals Inc changed between Q1 2024 and Q2 2024.

All holders in Q2 2024 All holders in Q1 2024

13F holders of ACAD: Q1 2024 compared with Q2 2024
Measure	Q1 2024	Of which not filed for Q2 2024	Q2 2024	Change
Holders	268	4	265	+1
Shares	161.6M	174.8K	161.2M	−275.8K (−0.2%)
Value	$2.99B	$3.21M	$2.62B	−$365.7M (−12.3%)

4 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (40)

Institutions that held Acadia Pharmaceuticals Inc at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to ACAD in Q2 2024
Institution	Shares	Value	% of portfolio
Jacobs Levy Equity Management, Inc	1,355,002	$22.0M	0.09%
Balyasny Asset Management LLC	772,146	$12.5M	0.03%
Dimensional Fund Advisors LP	649,150	$10.5M	0.00%
Neo Ivy Capital Management	203,048	$3.30M	0.65%
Bank of Montreal	96,225	$1.57M	0.00%
Sanctuary Advisors, LLC	91,834	$1.53M	0.01%
Mirae Asset Global ETFs Holdings Ltd.	83,137	$1.35M	0.00%
Corebridge Financial, Inc.	64,381	$1.05M	0.01%
Point72 Europe (London) LLP	50,600	$822.3K	0.07%
Cinctive Capital Management LP	44,378	$721.1K	0.04%
Scientech Research LLC	41,586	$675.8K	0.14%
Advantage Alpha Capital Partners LP	38,074	$618.7K	0.14%
XTX Topco Ltd	36,520	$593.5K	0.05%
Campbell & CO Investment Adviser LLC	36,122	$587.0K	0.05%
Bayesian Capital Management, LP	36,000	$585.0K	0.07%
Dark Forest Capital Management LP	32,910	$534.8K	0.10%
Gotham Asset Management, LLC	30,597	$497.2K	0.01%
HighVista Strategies LLC	25,878	$420.5K	0.15%
Atria Investments LLC	22,053	$358.4K	0.00%
Fox Run Management, L.L.C.	20,302	$329.9K	0.06%
Verition Fund Management LLC	18,829	$306.0K	0.00%
Vise Technologies, Inc.	17,162	$278.9K	0.05%
Shay Capital LLC	16,036	$260.6K	0.07%
Creative Planning	14,620	$237.6K	0.00%
Vident Advisory, LLC	14,179	$230.4K	0.01%
Entropy Technologies, LP	10,881	$176.8K	0.02%
NEOS Investment Management LLC	10,596	$172.2K	0.01%
DnB Asset Management AS	10,125	$164.5K	0.00%
Acadian Asset Management LLC	6,884	$111.0K	0.00%
New York State Teachers Retirement System	5,290	$86.0K	0.00%
Stonepine Capital Management, LLC	5,000	$81.3K	0.07%
KBC Group NV	3,049	$50.0K	0.00%
Smartleaf Asset Management LLC	425	$6.96K	0.00%
Ronald Blue Trust, Inc.	343	$6.34K	0.00%
Brown, Lisle/Cummings, Inc.	250	$4.06K	0.00%
Mather Group, LLC.	100	$1.85K	0.00%
Innealta Capital, LLC	86	$1.40K	0.00%
SRS Capital Advisors, Inc.	44	$715	0.00%
Concord Wealth Partners	10	$163	0.00%
Coppell Advisory Solutions LLC	4	$65	0.00%

Sold out (39)

Institutions that held Acadia Pharmaceuticals Inc at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of ACAD in Q2 2024
Institution	Shares, Q1 2024	Value, Q1 2024
Cutter Capital Management, LP	658,409	$12.2M
Avidity Partners Management LP	588,500	$10.9M
Candriam Luxembourg S.C.A.	405,751	$7.50M
Penn Capital Management Co Inc	248,844	$4.62M
Seven Eight Capital, LP	151,171	$2.80M
Twinbeech Capital LP	142,496	$2.63M
State of New Jersey Common Pension Fund D	112,270	$2.08M
Aquatic Capital Management LLC	101,200	$1.87M
Danske Bank A/S	87,573	$1.62M
Alyeska Investment Group, L.P.	85,696	$1.58M
Twin Tree Management, LP	76,887	$1.42M
Mutual of America Capital Management LLC	66,930	$1.24M
American International Group, Inc.	60,440	$1.12M
Crown Advisors Management, Inc.	30,000	$554.0K
ClariVest Asset Management LLC	28,335	$523.9K
Graham Capital Management, L.P.	23,238	$429.7K
Corton Capital Inc.	17,144	$317.0K
Cerity Partners LLC	12,992	$240.2K
Cantor Fitzgerald, L. P.	12,864	$237.7K
Pearl River Capital, LLC	11,920	$220.4K
Verity Asset Management, Inc.	11,668	$215.7K
Cetera Investment Advisers	11,559	$213.7K
Capstone Investment Advisors, LLC	11,403	$210.8K
Garrison Point Advisors, LLC	10,020	$185.3K
Metropolitan Life Insurance Co	6,624	$122.5K
Credit Agricole S A	2,500	$42.7K
Catalyst Funds Management Pty Ltd	1,600	$29.6K
Quantbot Technologies LP	900	$16.6K
Nelson, Van Denburg & Campbell Wealth Management Group, LLC	523	$9.67K
First Manhattan Co	375	$6.93K
Truvestments Capital LLC	199	$3.68K
Parallel Advisors, LLC	194	$3.59K
Anfield Capital Management, LLC	177	$3.27K
WealthCollab, LLC	93	$1.72K
Fuller & Thaler Asset Management, Inc.	73	$1.35K
Livelsberger Financial Advisory	75	$1.15K
Thurston, Springer, Miller, Herd & Titak, Inc.	53	$979
Cornerstone Planning Group LLC	50	$853
Bokf, NA	16	$292

Not filed for Q2 2024 yet (4)

Institutions that held Acadia Pharmaceuticals Inc at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ACAD in Q1 2024 that haven't filed for Q2 2024
Institution	Shares, Q1 2024	Value, Q1 2024
Credit Suisse AG	141,343	$2.61M
Cipher Capital LP	25,932	$479.5K
Shell Asset Management Co	6,904	$112.0K
Retirement Group, LLC	600	$1.55K